2.39

1.70% 0.04

Lunai Bioworks Inc (LNAI)

Overview News Price History Discussions Forecast

Lunai Bioworks Inc stock is traded at $2.39, with a volume of 12,501. It is up +1.70% in the last 24 hours and down -6.27% over the past month. Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Previous Close:

$2.35

Open:

$2.31

24h Volume:

12,501

Relative Volume:

0.02

Market Cap:

$10.84M

Revenue:

Net Income/Loss:

$-128.28M

P/E Ratio:

-0.039

EPS:

-61.2898

Net Cash Flow:

$-5.26M

1W Performance:

+0.84%

1M Performance:

-6.27%

6M Performance:

-21.59%

1Y Performance:

+0.00%

1-Day Range:

$2.301

$2.40

1-Week Range:

$2.15

$2.49

52-Week Range:

$1.2104

$13.28

Lunai Bioworks Inc Stock (LNAI) Company Profile

Name

Lunai Bioworks Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

45 39179840

Address

CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES

Employee

Twitter

Next Earnings Date

2026-08-21

Latest SEC Filings

LNAI's Discussions on Twitter

Compare LNAI vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LNAI Lunai Bioworks Inc	2.39	9.97M	0	-128.28M	-5.26M	-61.29
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Lunai Bioworks Inc Stock (LNAI) Latest News

Aug 19, 2026

Lunai (LNAI) Earnings Data Review: The Company Reports Its Latest Available Figures in the Latest Reading; Closing Response: The Market Price Declines 3.78% in the Latest ReadingNet Income Trends - vinanet.vn

Aug 19, 2026

Aug 17, 2026

Why Is LNAI Stock Skyrocketing Today? - Stocktwits

Aug 17, 2026

Aug 11, 2026

Lunai Bioworks Ord Shs (LNAI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 11, 2026

Aug 07, 2026

Lunai Bioworks (LNAI) Slips 1.44% to $2.40 as Biotech Traders Eye Key $2.28 SupportTake Profit Levels - vinanet.vn

Aug 07, 2026

Aug 05, 2026

Lunai Bioworks (LNAI) Slips 1.18% as Shares Test Key Support Near $2.39Block Trade Flow - dars.gov.et

Aug 05, 2026

Aug 04, 2026

Lunai Bioworks signs collaboration with BrainStorm Therapeutics - Investing.com

Aug 04, 2026

Lunai Bioworks files amended complaint alleging naked short selling - Investing.com

Aug 04, 2026

Lunai Bioworks signs collaboration with BrainStorm Therapeutics By Investing.com - Investing.com UK

Aug 04, 2026

Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement With BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027 - 富途牛牛

Aug 04, 2026

Lunai Bioworks files amended complaint alleging naked short selling By Investing.com - Investing.com India

Aug 04, 2026

Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit - Yahoo Finance

Aug 04, 2026

Aug 01, 2026

LNAI Q2 2026 Earnings: Biotech Posts $0.08 Per-Share Loss; Stock Retreats 3.96%Upward Estimate Revision - vinanet.vn

Aug 01, 2026

Jul 31, 2026

LNAI Q2 2026 Earnings: Reported Loss of -$0.08 Per Share as Stock Climbs 5.45%Analyst Earnings Estimate - vinanet.vn

Jul 31, 2026

Jul 30, 2026

Lunai Bioworks (LNAI) Declines 4.27%, Testing Key Support Near $1.92Unusual Put Volume - dars.gov.et

Jul 30, 2026

LNAI Q2 2026 Earnings: Pre-Revenue Biotech Reports Narrower Loss; Stock Falls 5.21%Retail Earnings Report - vinanet.vn

Jul 30, 2026

Jul 29, 2026

LNAI: Lunai Bioworks Inc.Financial Overview - Zacks Investment Research

Jul 29, 2026

Jul 28, 2026

Lunai Bioworks Holds Steady at $2.24: Consolidation Phase Amid Key SupportVolume Rate Change - vinanet.vn

Jul 28, 2026

Lunai Bioworks Ord Shs (LNAI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 25, 2026

Jul 20, 2026

Lunai Bioworks(LNAI) Stock Options Chain | Quotes & News - Moomoo

Jul 20, 2026

Jul 17, 2026